A 37-year-old man in the UK just became the world's first human test subject for a new, experimental Ebola vaccine. His name is Ed Hunt, and apparently, he's the kind of guy who sees a deadly outbreak in the Democratic Republic of Congo and thinks, "Yeah, I can help with that."
Turns out, this medical marvel was whipped up by Oxford scientists in a mere eight weeks. Eight. Weeks. For context, some of us can't even pick a Netflix show that fast. The secret weapon? The same tech that powered one of the UK's COVID vaccines. Because apparently that's where we are now: borrowing vaccine platforms like they're a cup of sugar from next door.
From COVID to Congo
Hunt is the inaugural volunteer in a trial that will eventually include 50 healthy adults, all between 18 and 55. He'd actually wanted to join a COVID vaccine trial, but life (and work) got in the way. So, when news of the DR Congo outbreak hit, he saw his chance to contribute to humanity's ongoing fight against… well, everything.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxProfessor Teresa Lamb, who led the Oxford team, pointed out that decades of research laid the groundwork for this speedy creation. No, the trial won't actually give anyone Ebola. That would be, shall we say, counterproductive. Instead, the goal is to make sure it's safe and that it kicks the immune system into high gear to fight off the Bundibugyo strain of the virus.
Now, there's already a licensed vaccine for the Zaire species of Ebola, but it's a bit of a one-trick pony and doesn't work against Bundibugyo. So, this new Oxford jab is the first of four Bundibugyo-specific vaccines to reach human trials. Which, if you think about it, is both impressive and slightly terrifying.
The Oxford crew isn't stopping there. They're planning a second small trial in Uganda, with a larger-scale efficacy study to follow in DR Congo. And just in case things go well, the Serum Institute in India has already pre-produced 600,000 doses. Because nothing says "optimism" like having half a million vaccines waiting in the wings.
So far, DR Congo has reported over 2,500 confirmed Ebola cases, with more than 1,000 deaths. Let that sobering number sink in. Then, maybe give a silent nod to Ed Hunt and the scientists who are trying to make it a little less terrifying.
